Related Experiment Video
Updated: Aug 10, 2026

Detection of Modified Forms of Cytosine Using Sensitive Immunohistochemistry
Published on: August 16, 2016
Alkylation of DNA and its aftermath
1Haddow Laboratories, Institute of Cancer Research, Sutton, Surrey, UK.
Abstract:
Current pharmacopoeias invariably refer to a category of 'alkylating drugs', still among the most widely used in cancer chemotherapy. They are described as acting through their ability to damage DNA, thus interfering with cell replication. Unfortunately, this mode of action implicates these drugs as carcinogens. Thus the early studies recalled in this essay proved to be relevant to our understanding of both the main problems with which cancer research concerns itself: the causation of cancer and possible methods of treatment of this group of diseases.
Insights
Alkylating drugs are widely used in cancer chemotherapy by damaging DNA, but this also makes them carcinogenic. Early research highlighted their dual role in cancer causation and treatment.
Area of Science:
- Oncology
- Pharmacology
- Genetics
Background:
- Alkylating drugs are a cornerstone of modern cancer chemotherapy.
- Their mechanism involves DNA damage to inhibit cancer cell replication.
- A significant concern is their inherent carcinogenicity.
Purpose of the Study:
- To review the historical context of alkylating drugs in cancer research.
- To connect their DNA-damaging action to both cancer causation and treatment strategies.
- To underscore the dual nature of these agents in oncology.
Main Methods:
- Literature review of early studies on alkylating agents.
- Analysis of pharmacopoeial classifications.
- Discussion of DNA damage mechanisms.
Main Results:
- Alkylating drugs are classified and widely used in cancer treatment.
- DNA damage is the primary mode of action for these drugs.
- The DNA-damaging property is directly linked to their carcinogenic potential.
Conclusions:
- Understanding alkylating drugs is crucial for addressing cancer causation.
- These agents represent a critical area for research in cancer treatment modalities.
- The dual role of alkylating drugs necessitates careful consideration in cancer therapy and prevention.
Related Concept Videos
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...
Homologous Recombination
Gene Conversion
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

